Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group N9831 adjuvant trastuzumab trial Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols
  • Biomarkers, Tumor
  • Breast Neoplasms
  • Molecular Targeted Therapy
  • Receptor, ErbB-2

abstract

  • Increased expression of a subset of immune function genes may provide a means of predicting benefit from adjuvant trastuzumab.

publication date

  • March 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4334774

Digital Object Identifier (DOI)

  • 10.1200/JCO.2014.57.6298

PubMed ID

  • 25605861

Additional Document Info

start page

  • 701

end page

  • 8

volume

  • 33

number

  • 7